Cavalry Biosciences
PrivateLast Round
Series B
Jun 8, 2026
Total Funding Raised
$40.27M
Company Overview
Cavalry Biosciences is a biotechnology company developing therapeutic drugs to treat rare and chronic diseases by engineering tissue-selective growth factors and cytokines.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cavalry Biosciences Comps
Public and private peers based on sector, stage, and business model.
Cavalry Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 8, 2026 | ||||
| Grant | Sep 22, 2023 | ||||
| Series A | Nov 1, 2021 |
Cavalry Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lilly Ventures | Series A |
| NIH RADx | Grant |
| Mission BioCapital | Series A |
| Venrock | Series A |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 8, 2026
Raised $75M in Series B funding.
- Apr 4, 2026
Monthly visitors increased 70% MoM.
Cavalry Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cavalry Biosciences's valuation, stock price, and market status.
